Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

ClinicalTrials.gov ID: NCT02670785

Public ClinicalTrials.gov record NCT02670785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 7:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate Safety and Efficacy of Three Doses of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will access the safety and efficacy of three doses of estradiol vaginal capsules in postmenopausal women with vulvovaginal atrophy.

Study identification

NCT ID
NCT02670785
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Warner Chilcott
Industry
Enrollment
203 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 15, 2016 (Actual)
Primary completion
Nov 14, 2016 (Actual)
Completion
Nov 14, 2016 (Actual)
Last update posted
Aug 23, 2017

2016

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Visions Clinical Research-Tucson Tucson Arizona 85712 —
Genesis Center for Clinical Research San Diego California 92103 —
Coastal Connecticut Research, LLC New London Connecticut 06320 —
Women's Medical Research Group, LLC Clearwater Florida 33759 —
Radiant Research, Inc. Pinellas Park Florida 33781 —
Comprehensive Clinical Trials, LLC West Palm Beach Florida 33409 —
Fellows Research Alliance, Inc Savannah Georgia 31406 —
Beyer Research Kalamazoo Michigan 49009 —
Office of R. Garn Mabey, M.D. Las Vegas Nevada 89128 —
Carolina Women's Research and Wellness Center Durham North Carolina 27713 —
Hawthorne Medical Research, Inc. Winston-Salem North Carolina 27103 —
Rapid Medical Research, Inc. Cleveland Ohio 44122 —
Women's Health Research Columbus Ohio 43213 —
Clinical Research of Philadelphia, LLC Philadelphia Pennsylvania 19114 —
Fellows Research Alliance, Inc Bluffton South Carolina 29910 —
Radiant Research, Inc. Dallas Texas 75231 —
Radiant Research, Inc. San Antonio Texas 78229 —
Virginia Women's Center Richmond Virginia 23233 —
Seattle Women's Health, Research, Gynecology Seattle Washington 98105 —
North Spokane Women's Clinic Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02670785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02670785 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →